LONDON (Reuters) – Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi
The newspaper said that Britain was considering taking an option to buy the vaccine should it work in human trials, which are due to begin in September.
(Reporting by Alistair Smout;Editing by Elaine Hardcastle)




